These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 4147030)

  • 1. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma.
    Truitt RL; Rimm AA; Saltzstein EC; Rose WC; Bortin MM
    Transplant Proc; 1976 Dec; 8(4):569-74. PubMed ID: 11589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cells.
    Bortin MM; Rimm AA; Rose WC; Saltzstein EC
    Transplantation; 1974 Sep; 18(3):280-3. PubMed ID: 4154022
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the influence of a graft-versus-host reaction, induced by parent line cells, on the growth of lymphoma transplants in F1 hybrid mice.
    Palmer AM; Symes MO
    Folia Biol (Praha); 1974; 20(1):26-35. PubMed ID: 4154872
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of graft-versus-host-reaction (GVHR) by in vitro incubation of donor lymphocytes with thymic or splenic chalone (s).
    Kiger N; Florentin I; Garcia-Giralt E; Mathé G
    Exp Hematol; 1973; 1(1):22-8. PubMed ID: 4153630
    [No Abstract]   [Full Text] [Related]  

  • 7. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 8. Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Flinton LJ; Simon JD; Kelley RJ; Albala MM
    Cancer Res; 1977 Oct; 37(10):3494-6. PubMed ID: 20223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host-induced immunosuppression. The effect of antigenic stimulation on cell-mediated and humoral immune responses.
    Treiber W; Lapp WS
    Transplantation; 1973 Sep; 16(3):211-6. PubMed ID: 4147031
    [No Abstract]   [Full Text] [Related]  

  • 11. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide.
    Truitt RL; Rose WC; Rimm AA; Bortin MM
    Exp Hematol; 1978 May; 6(5):488-98. PubMed ID: 26584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxin.
    Rose WC; Rodey GE; Rimm AA; Truitt RL; Bortin MM
    Exp Hematol; 1976 Mar; 4(2):90-6. PubMed ID: 4335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocompetent cell functions in mice infected with Friend leukemia virus.
    Bennett M; Steeves RA
    J Natl Cancer Inst; 1970 May; 44(5):1107-19. PubMed ID: 4398242
    [No Abstract]   [Full Text] [Related]  

  • 14. Time pattern of the antileukemic effect of graft-versus-host reaction in mice.
    Boranić M; Tonković I
    Cancer Res; 1971 Aug; 31(8):1140-7. PubMed ID: 4398523
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunocompetent lymphoi- cells from pregnant mice studied in the graft-versus-host reaction].
    Dukova VS; Fedosov EA
    Biull Eksp Biol Med; 1977 Mar; 83(3):310-12. PubMed ID: 15684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular immune capacity of mice with transplanted lymphoid leukaemia.
    Boranic M; Poljak-Blazi M
    Biomedicine; 1976 Jun; 25(4):141-4. PubMed ID: 782579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymus dependence of lymphocyte trapping.
    Zatz MM; Gershon RK
    J Immunol; 1974 Jan; 112(1):101-6. PubMed ID: 4149589
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.